| ［1］ Akgul C, Turner P C, White M R, et al. Functional analysis of the human Mcl-1 gene. Cell Mol Life Sci, 2000,57:684~691 ［2］ Wolfgang S, Doris L, Sabine S, et al. Mcl-1 overexpression in hepatocellular carcinoma: A potential target for antisense therapy. Journal of Hepatology, 2006,44:151~157 ［3］ Kshama J, Christie L G, Rhonda F S, et al. Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett’s cell line. Am J Physiol Gastrointest Liver Physiol, 2006,290: G335~G342 ［4］ Hugh K A, Rosalie C S. Protein phosphatase 2A regulatory subunit B56_associates with c-Myc and negatively regulates c-Myc accumulation. Molecular and Cellular Biology,2006,26(7):2832~2844 ［5］ Krajewski S, Bodrug S, Krajewska M, et al. Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol, 1995,146:1309~1319 ［6］ Osford S M, Dallman C L, Johnson P W, et al. Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cells. Curr Med Chem, 2004, 11(8): 1031~1039 ［7］ Saxena A, Viswanathan S, Moshynska O, et al. Mcl-1 and Bcl-2 /Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia.Am J Hematol, 2004, 75(1): 22~33 ［8］ Toledo A, Yamaguchi J, Wang J Y, et al. Taurodeoxycholate stimulates intestinal cell proliferation and protects against apoptotic cell death through activation of NFkappa B. Dig Dis Sci, 2004, 49: 1664~1671 ［9］ Pai R, Tarnawski A S, Tran T. Deoxycholic acid activates betacatenin signaling pathway and increases colon cell cancer growth and invasiveness. Mol Biol Cell, 2004,15: 2156~2163 ［10］ Yuko T, Toshio K, Naoki M, et al. Irinotecan activates p53 with its active metabolite, resulting in human hepatocellular carcinoma apoptosis. J Pharmacol Sci, 2007,104:232~242 |
